Characterization of serum micrornas profile of PCOS and identification of novel non-invasive biomarkers

Cellular Physiology and Biochemistry

Volumn 33, Issue 5, 2014, Pages 1304-1315

  Long, Wei ^a   Zhao, Chun ^a   Ji, Chenbo ^a   Ding, Hongjuan ^a   Cui, Yugui ^a   Guo, Xirong ^a   Shen, Rong ^a   Liu, Jiayin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Biomarkers; Microarray; MicroRNA; PCOS

Indexed keywords

BIOLOGICAL MARKER; ESTRADIOL; GLUCOSE; INSULIN; LUTEINIZING HORMONE; MICRORNA; MICRORNA 106B; MICRORNA 146A; MICRORNA 16; MICRORNA 186; MICRORNA 19A; MICRORNA 222; MICRORNA 24; MICRORNA 30C; MICRORNA 320; PROLACTIN; TESTOSTERONE; UNCLASSIFIED DRUG; MIRN146 MICRORNA, HUMAN; MIRN222 MICRORNA, HUMAN; MIRN30 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; APOPTOSIS; ARTICLE; BIOINFORMATICS; BODY MASS; CELL CYCLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SERUM; METASTASIS; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TESTOSTERONE BLOOD LEVEL; AREA UNDER THE CURVE; DISEASE ASSOCIATION; DISEASE MARKER; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RNA ANALYSIS; SYSTEMATIC REVIEW; VALIDATION STUDY; BIOLOGY; BLOOD; GENE EXPRESSION PROFILING; GENETICS; PATHOLOGY; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

ADULT; APOPTOSIS; CELL CYCLE; COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MICRORNAS; POLYCYSTIC OVARY SYNDROME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84899589108     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000358698     Document Type: Article

References (33)

1. Dunaif A: Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800. (Pubitemid 28009567)
2. Norman RJ, Dewailly D, Legro RS, Hickey TE: Polycystic ovary syndrome. Lancet 2007;370:685-697. (Pubitemid 47285318)
3. Azziz R Carmina E Dewailly D Diama nti-Kandarakis E Escobar-Morreale HF Futterweit W Janssen OE Legro RS Norman RJ Taylor AE Witchel SF The androgen excess and pcos society criteria for the polycystic ovary syndrome: The complete task force report. Fertil Steril 2009 91 456-488.
4. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (pcos). Hum Reprod 2004;19:41-47.
5. Fr anks S, McCarthy MI, Hardy K: Development of polycystic ovary syndrome: Involvement of genetic and environmental factors. Int J Androl 2006;29:278-285; discussion 286-290.
6. He L, Hannon GJ: Microrna s: Small rnas with a big role in gene regulation. Nat Rev Genet 2004;5:522-531. (Pubitemid 38868508)
7. Li W, Ruan K: Microrna detection by microarray. Anal Bioanal Chem 2009;394:1117-1124.
8. Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, Chan EK: Upregulated mir-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 2008;10:R101.
9. Jones SW, Watkins G, Le Good N, Roberts S, Murphy CL, Brockbank SM, Needham MR, Read SJ, Newham P: The identification of differentially expressed microrna in osteoarthritic tissue that modulate the productio n of tnf-alpha and mmp13. Osteoarthritis Cartilage 2009;17:464-472.
10. Teague EM, Print CG, Hull ML: The role of micrornas in endometriosis and associated reproductive conditions. Hum Reprod Update 2010;16:142-165.
11. McCallie B, Schoolcraft WB, Katz-Jaffe MG: Aberration of blastocyst microrna expression is associated with human infertility. Fertil Steril 2010;93:2374-2382.
12. Ch en X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Go n g T, Ning G, Zen K, Zhang CY: Characterization of micrornas in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997-1006.
13. Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z, Sun F, Lu J, Yin Y, Cai X, Sun Q Wang K, Ba Y, Wang Q Wang D, Yang J, Liu P, Xu T, Yan Q, Zhang J, Zen K, Zhang CY: Secreted monocytic mir-150 enhances targeted en dothelial cell migration. Mol Cell 2010;39:133-144.
14. Kroh EM, Parkin RK, Mitchell PS, Tewari M: Analysis of circulating microrna biomarkers in plasma and serum using quantitative reverse transcription-pc r (qrt-pcr). Methods 2010;50:298-301.
15. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M: Circulating micrornas as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008;105:10513-10518.
16. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ: Real-time quantification of m icrornas by stem-loop rt-pcr. Nucleic Acids Res 2005;33:e179.
17. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA , Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G: Gene ontology: Tool for the unification of biology. The gene ontology consortium. Nat Genet 2000 ;25:25-29. (Pubitemid 30257031)
18. Papadopoulos GL, Alexiou P, Maragkakis M, Reczko M, Hatzigeorgiou AG: Diana-mirpath: Integrating human and mouse micrornas in pathways. Bioinformatics 2009;25:1991-1993.
19. Kanehisa M, Goto S: Kegg: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000;28:27-30. (Pubitemid 30047706)
20. Laven JS, Imani B, Eijkemans MJ, Fauser BC: New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv 2002;57:755-767. (Pubitemid 35379455)
21. Legro RS, Kunselman AR, Dunaif A: Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 2001;111:607-613. (Pubitemid 34088070)
22. Escobar-Morreale HF, Asuncion M, Calvo RM, Sancho J, San Millan JL: Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiologica l studies. Eur J Endocrinol 2001;145:619-624. (Pubitemid 33069338)
23. Koskinen P, Penttila TA, Anttila L, Erkkola R, Irjala K: Optimal use of hormone determinations in the biochemical diagnosis of the polycystic ovary synd rome. Fertil Steril 1996;65:517-522. (Pubitemid 26069105)
24. Turhan NO Toppare MF Seckin NC Dilmen G The predictive power of endocrine tests for the diagnosis of polycystic ovaries in women with oligoamenorrhea Gynec ol Obstet Invest 1999, 48 183-186. (Pubitemid 29488322)
25. Pall ME, Lao MC, Patel SS, Lee ML, Ghods DE, Chandler DW, Friedman TC: Testosterone and bioavailable testosterone help to distinguish between mild cushing's sy ndrome and polycystic ovarian syndrome. Horm Metab Res 2008;40:813-818. (Pubitemid 352772695)
26. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C, Shen H: Serum microrna signatures identified in a genome-wide serum microrna expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 2010;28:1721-1726.
27. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Po on TC, Ng SS, Sung JJ: Differential expression of micrornas in plasma of patients with colorectal cancer: A potential marker for colorectal cancer screening. Gut 2009;58:1375-1381.
28. Fichtlscherer S, De R osa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Roxe T, Muller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S: Circulating micrornas in patients with coronary artery disease. Circ Res 2010;107:677-6 84.
29. Ai J, Zhang R, Li Y, Pu J, Lu Y, Jiao J, Li K, Yu B, Li Z, Wang R, Wang L, Li Q, Wang N, Shan H, Yang B: Circulating microrna-1 as a potential novel biomarker for acute myocard ial infarction. Biochem Biophys Res Commun 2010;391:73-77.
30. Baley J, Li J: Micrornas and ovarian function. J Ovarian Res 2012;5:8.
31. Ortega FJ, Mercader JM, Moreno-Na varrete JM, Rovira O, Guerra E, Esteve E, Xifra G, Martinez C, Ricart W, Rieusset J, Rome S, Karczewska-Kupczewska M, Straczkowski M, Fernandez-Real JM: Profiling of circulating micrornas reveals common mic rornas linked to type 2 diabetes that change with insulin sensitization. Diabetes Care 2014
32. Sirotkin AV, Ovcharenko D, Grossmann R, Laukova M, Mlyncek M: Identification of micrornas controlling human ovarian cell st eroidogenesis via a genome-scale screen. J Cell Physiol 2009;219:415-420.
33. Git A, Dvinge H, Salmon-Divon M, Osborne M, Kutter C, Hadfield J, Bertone P, Caldas C: Systematic comparison of microarray profiling, real-time pcr, and next-generation sequencing technologies for measuring differential microrna expression. RNA 2010;16:991-1006.